| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VERACYTE INC | 3,513,161 | 27,192,000 | 10.11% | ||
| 2 | Lion Biotechnologies | 3,809,944 | 26,479,000 | 9.85% | ||
| 3 | IRIDEX CORP COM | 1,554,146 | 21,851,000 | 8.13% | ||
| 4 | IMMUNOMEDICS INC | 4,700,000 | 17,249,000 | 6.41% | ||
| 5 | NEURODERM LTD | 665,944 | 14,784,000 | 5.50% | ||
| 6 | EDGE THERAPEUTICS INC | 1,040,265 | 13,003,000 | 4.84% | ||
| 7 | ASSEMBLY BIOSCIENCES INC | 976,599 | 11,866,000 | 4.41% | ||
| 8 | Ascendis Pharma | 575,309 | 11,644,000 | 4.33% | ||
| 9 | IMMUNOMEDICS INC | 10,500,000 | 10,395,000 | 3.87% | PRN | |
| 10 | ACLARIS THERAPEUTICS INC COM | 372,753 | 10,117,000 | 3.76% | ||
| 11 | ISHARES TR | 70,000 | 9,440,000 | 3.51% | Put | |
| 12 | ACADIA PHARMACEUTICALS INC COM | 300,000 | 8,652,000 | 3.22% | ||
| 13 | CHEMBIO DIAGNOSTICS INC COM NEW | 1,150,925 | 7,826,000 | 2.91% | ||
| 14 | AKEBIA THERAPEUTICS INC | 698,825 | 7,275,000 | 2.71% | ||
| 15 | Oxford Immunotec Global PLC | 470,834 | 7,039,000 | 2.62% | ||
| 16 | MARVELL TECHNOLOGY GROUP LTD | 500,000 | 6,935,000 | 2.58% | ||
| 17 | CAS MED SYS INC | 4,179,838 | 6,730,000 | 2.50% | ||
| 18 | RA PHARMACEUTICALS INC | 377,909 | 5,740,000 | 2.13% | ||
| 19 | GW PHARMACEUTICALS PLC | 40,000 | 4,470,000 | 1.66% | ||
| 20 | Nabriva Therapeutics AG | 706,383 | 4,210,000 | 1.57% | ||
| 21 | WebMD Health Corp | 80,000 | 3,966,000 | 1.47% | ||
| 22 | DBV TECHNOLOGIES | 91,898 | 3,228,000 | 1.20% | ||
| 23 | VERACYTE INC | 375,000 | 2,903,000 | 1.08% | Call | |
| 24 | DERMIRA INC | 88,500 | 2,684,000 | 1.00% | ||
| 25 | VANDA PHARMACEUTICALS INC COM | 162,600 | 2,593,000 | 0.96% | ||
| 26 | SOCIETAL CDMO INC | 300,000 | 2,418,000 | 0.90% | ||
| 27 | AURINIA PHARMACEUTICALS INC | 1,000,000 | 2,100,000 | 0.78% | ||
| 28 | AERIE PHARMACEUTICALS INC | 50,000 | 1,893,000 | 0.70% | ||
| 29 | Clearside Biomedical Inc | 175,000 | 1,565,000 | 0.58% | ||
| 30 | ZIMMER BIOMET HLDGS INC | 15,000 | 1,548,000 | 0.58% | ||
| 31 | SAREPTA THERAPEUTICS INC | 50,000 | 1,372,000 | 0.51% | Put | |
| 32 | ESSA Pharma | 605,300 | 1,330,000 | 0.49% | ||
| 33 | EXELIXIS INC | 80,000 | 1,193,000 | 0.44% | Put | |
| 34 | ALIMERA SCIENCES INC | 974,318 | 1,052,000 | 0.39% | ||
| 35 | Lion Biotechnologies | 150,000 | 1,043,000 | 0.39% | Call | |
| 36 | BIOCRYST PHARMACEUTICALS | 150,000 | 950,000 | 0.35% | ||
| 37 | ROCKWELL MED INC COM | 140,000 | 917,000 | 0.34% | Put | |
| 38 | AMICUS THERAPEUTICS INC | 145,300 | 722,000 | 0.27% | ||
| 39 | SPECTRANETICS CORP | 27,500 | 674,000 | 0.25% | ||
| 40 | BIOCRYST PHARMACEUTICALS | 99,000 | 627,000 | 0.23% | Call | |
| 41 | ARDELYX INC COM | 26,891 | 382,000 | 0.14% | ||
| 42 | IMMUNOMEDICS INC | 100,000 | 367,000 | 0.14% | Call | |
| 43 | ASSEMBLY BIOSCIENCES INC | 10,000 | 122,000 | 0.05% | Call | |
| 44 | ONCOBIOLOGICS INC | 29,082 | 88,000 | 0.03% | ||
| 45 | ENDOLOGIX INC | 96,000 | 86,000 | 0.03% | PRN | |
| 46 | ONCOBIOLOGICS INC - WARRANT B | 96,833 | 76,000 | 0.03% | ||
| 47 | MANNKIND CORPORATION | 90,000 | 58,000 | 0.02% | Put | |
| 48 | PLURISTEM THERAPEUTICS INC | 21,100 | 30,000 | 0.01% | Put | |
| 49 | ONCOBIOLOGICS INC - WARRANT A | 96,833 | 18,000 | 0.01% | ||
| 50 | OHR PHARMACEUTICAL INC | 10,000 | 15,000 | 0.01% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-17-001423, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
